SPIRONOLACTONE 25 MG TABLET
For 30 tablets
Pharmacies pay
$1.28 filed
30 × $0.04264 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$3.98 filed
30 × $0.13256 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
3.1× estimated
Medicare paid 3.1× what pharmacies pay.
Part D averages every strength and form sold under “Spironolactone” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$6.47 estimated
$1.28 + $0.19 (15%) + $5.00 fee per fill = $6.47
This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
SPIRONOLACTONE 25 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as spironolactone.
FDA gives its dosage form as “tablet, film coated”, “tablet” and “tablet, coated” and its route as oral.
FDA lists 13 labelers (the companies named on the label) for its NDCs, among them Mylan Pharmaceuticals Inc., Major Pharmaceuticals and Camber Pharmaceuticals, Inc.
FDA’s Established Pharmacologic Class for it is Aldosterone Antagonist.
The NADAC file of 2026-10-14 prices it under 34 NDCs (National Drug Codes); the FDA directory lists 32 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $1.28 for 30 tablets (30 × $0.04264 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 13 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Oxford Pharmaceuticals, LLC | 4 | $0.04264 per EA filed |
| Amneal Pharmaceuticals of New York LLC | 3 | $0.04264 per EA filed |
| Aurobindo Pharma Limited | 3 | $0.04264 per EA filed |
| Camber Pharmaceuticals, Inc. | 3 | $0.04264 per EA filed |
| Jubilant Cadista Pharmacuticals Inc. | 3 | $0.04264 per EA filed |
| NorthStar Rx LLC | 3 | $0.04264 per EA filed |
| Sun Pharmaceutical Industries, Inc. | 3 | $0.04264 per EA filed |
| Zydus Pharmaceuticals (USA) Inc. | 3 | $0.04264 per EA filed |
| Mylan Pharmaceuticals Inc. | 2 | $0.04264 per EA filed |
| Rising Pharma Holdings, Inc. | 2 | $0.04264 per EA filed |
| American Health Packaging | 1 | $0.04264 per EA filed |
| Major Pharmaceuticals | 1 | $0.04264 per EA filed |
| Mylan Institutional Inc. | 1 | $0.04264 per EA filed |
| Not listed as a package in the FDA directory | 2 | $0.04264 per EA filed |
All 34 NDCs, with labeler and price
- 00378-2146-01 · Mylan Pharmaceuticals Inc. · $0.04264 per EA · eff. 2026-09-23 filed
- 00378-2146-05 · Mylan Pharmaceuticals Inc. · $0.04264 per EA · eff. 2026-09-23 filed
- 00904-6927-61 · Major Pharmaceuticals · $0.04264 per EA · eff. 2026-09-23 filed
- 31722-0094-01 · Camber Pharmaceuticals, Inc. · $0.04264 per EA · eff. 2026-09-23 filed
- 31722-0094-05 · Camber Pharmaceuticals, Inc. · $0.04264 per EA · eff. 2026-09-23 filed
- 31722-0094-10 · Camber Pharmaceuticals, Inc. · $0.04264 per EA · eff. 2026-09-23 filed
- 51079-0103-01 · not listed as a package in the FDA directory · $0.04264 per EA · eff. 2026-09-23 filed
- 51079-0103-20 · Mylan Institutional Inc. · $0.04264 per EA · eff. 2026-09-23 filed
- 53489-0143-01 · Sun Pharmaceutical Industries, Inc. · $0.04264 per EA · eff. 2026-09-23 filed
- 53489-0143-05 · Sun Pharmaceutical Industries, Inc. · $0.04264 per EA · eff. 2026-09-23 filed
- 53489-0143-10 · Sun Pharmaceutical Industries, Inc. · $0.04264 per EA · eff. 2026-09-23 filed
- 53746-0511-01 · Amneal Pharmaceuticals of New York LLC · $0.04264 per EA · eff. 2026-09-23 filed
- 53746-0511-05 · Amneal Pharmaceuticals of New York LLC · $0.04264 per EA · eff. 2026-09-23 filed
- 53746-0511-10 · Amneal Pharmaceuticals of New York LLC · $0.04264 per EA · eff. 2026-09-23 filed
- 59651-0426-01 · Aurobindo Pharma Limited · $0.04264 per EA · eff. 2026-09-23 filed
- 59651-0426-05 · Aurobindo Pharma Limited · $0.04264 per EA · eff. 2026-09-23 filed
- 59651-0426-99 · Aurobindo Pharma Limited · $0.04264 per EA · eff. 2026-09-23 filed
- 59746-0216-05 · Jubilant Cadista Pharmacuticals Inc. · $0.04264 per EA · eff. 2026-09-23 filed
- 59746-0216-06 · Jubilant Cadista Pharmacuticals Inc. · $0.04264 per EA · eff. 2026-09-23 filed
- 59746-0216-09 · Jubilant Cadista Pharmacuticals Inc. · $0.04264 per EA · eff. 2026-09-23 filed
- 60687-0465-01 · American Health Packaging · $0.04264 per EA · eff. 2026-09-23 filed
- 60687-0465-11 · not listed as a package in the FDA directory · $0.04264 per EA · eff. 2026-09-23 filed
- 64980-0706-01 · Rising Pharma Holdings, Inc. · $0.04264 per EA · eff. 2026-09-23 filed
- 64980-0706-50 · Rising Pharma Holdings, Inc. · $0.04264 per EA · eff. 2026-09-23 filed
- 68382-0660-01 · Zydus Pharmaceuticals (USA) Inc. · $0.04264 per EA · eff. 2026-09-23 filed
- 68382-0660-05 · Zydus Pharmaceuticals (USA) Inc. · $0.04264 per EA · eff. 2026-09-23 filed
- 68382-0660-10 · Zydus Pharmaceuticals (USA) Inc. · $0.04264 per EA · eff. 2026-09-23 filed
- 69584-0852-10 · Oxford Pharmaceuticals, LLC · $0.04264 per EA · eff. 2026-09-23 filed
- 69584-0852-50 · Oxford Pharmaceuticals, LLC · $0.04264 per EA · eff. 2026-09-23 filed
- 69584-0852-90 · Oxford Pharmaceuticals, LLC · $0.04264 per EA · eff. 2026-09-23 filed
- 69584-0852-92 · Oxford Pharmaceuticals, LLC · $0.04264 per EA · eff. 2026-09-23 filed
- 72603-0134-01 · NorthStar Rx LLC · $0.04264 per EA · eff. 2026-09-23 filed
- 72603-0134-02 · NorthStar Rx LLC · $0.04264 per EA · eff. 2026-09-23 filed
- 72603-0134-03 · NorthStar Rx LLC · $0.04264 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
3 other products in the NADAC file share the FDA nonproprietary name spironolactone with SPIRONOLACTONE 25 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| SPIRONOLACTONE 25 MG TABLET this page | $0.04264 per EA filed | $0.13256 per EA filed |
| SPIRONOLACTONE 25 MG/5 ML SUSP | $1.61922 to $1.81187 per ML filed | We don’t know yet |
| SPIRONOLACTONE 50 MG TABLET | $0.08319 per EA filed | $0.13256 per EA filed |
| SPIRONOLACTONE 100 MG TABLET | $0.16783 per EA filed | $0.13256 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 34 NDCs’ NADAC prices is $0.04264 per EA filed.
Of the 5 other products in FDA’s Aldosterone Antagonist class priced per EA, 5 have a higher middle NADAC price and 0 a lower one. The one in the middle is EPLERENONE 25 MG TABLET, at $0.30799 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $3.98 for 30 tablets, at an average of $0.13256 per EA in 2024 (2024-01-01 to 2024-12-31) for “Spironolactone”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 9,081,323 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for SPIRONOLACTONE 25 MG TABLET labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Spironolactone / Spironolactone: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name. 82 of 88 NADAC NDCs joined to this name are priced per EA (6 per ML): CMS's average mixes those units.